NATHBIOGENBSENath Bio-Genes (India) LtdMinimalNeutral
Announced Thu, 28 May · 12:04 IST

Annual Secretarial Compliance Report for 31st March 2026.

NATHBIOGEN · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
+1.4%1-day move
₹174.00
prior close
₹172.20
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
+0.9+0.6-0.1+0.5+1.4+0.1-0.8-0.7-3.4-3.4-7.6-4.8
Up moveDown movePending
AI summary

Nath Bio-Genes (India) Ltd has filed its Annual Secretarial Compliance Report for FY2025-26 with BSE and NSE. The report has been issued by M/s Neha P Agrawal, Practicing Company Secretaries, as required under Regulation 24A of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. This is a mandatory annual compliance filing for listed companies. The actual report details were enclosed with this transmittal letter dated 28th May 2026 and signed by CFO Amol Gupta.

Likely market impact

This is a routine regulatory compliance filing. A clean secretarial compliance report indicates proper adherence to SEBI listing norms. It does not directly impact financials or operations but confirms the company maintained good governance standards during FY2025-26.